Evidence map›Paper›PMID 37311905›Full record

ArticleCommunications biology2023

Complete remission of diabetes with a transient HDAC inhibitor and insulin in streptozotocin mice.

Hideto Kojima, Miwako Katagi, Junko Okano, Yuki Nakae, Natsuko Ohashi, Kazunori Fujino, Itsuko Miyazawa, Takahiko Nakagawa

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Aberrant peripheral blood CD34Practical laboratory medicine · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Screening H3 Histone Acetylation in a Wild Bird, the House Sparrow (Integrative organismal biology (Oxford, England) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hideto Kojima *Department of Biocommunication Development, Shiga University of Medical Science, Otsu, Japan. kojima@belle.shiga-med.ac.jp.ORCID 0000-0002-4781-2052
Miwako Katagi *Department of Biocommunication Development, Shiga University of Medical Science, Otsu, Japan.
Junko OkanoDepartment of Plastic and Reconstructive Surgery, Shiga University of Medical Science, Otsu, Japan.
Yuki NakaeDepartment of Regenerative Medicine Development, Shiga University of Medical Science, Otsu, Japan.
Natsuko OhashiDepartment of Medicine, Division of Diabetology, Endocrinology and Nephrology, Shiga University of Medical Science, Otsu, Japan.
Kazunori FujinoDepartment of Critical and Intensive Care Medicine, Shiga University of Medical Science, Otsu, Japan.
Itsuko MiyazawaDepartment of Education Center for Medicine and Nursing, Shiga University of Medical Science, Otsu, Japan.
Takahiko NakagawaDepartment of Biocommunication Development, Shiga University of Medical Science, Otsu, Japan. takahiko@belle.shiga-med.ac.jp.ORCID 0000-0002-0127-1529
Shiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the growing epidemic worldwide, diabetes is an incurable disease. We have been focusing on why diabetes manifests refractoriness to any therapy. We recently found that abnormal bone marrow-derived cells (BMDCs), namely, Vcam-1

Indexed as

Diabetes Mellitus, ExperimentalInsulinAnimalsCarbamatesHistone Deacetylase InhibitorsInsulin, Regular, HumanMiceStreptozocinCarbamatesgivinostatHistone Deacetylase InhibitorsInsulinInsulin, Regular, HumanStreptozocin

Identifiers

PMID37311905
PMCPMC10264456
OpenAlexW4380576521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.